Mule S, Chalaye J, Legou F, Tenenhaus A, et al. Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT. Eur Radiol 2020 May 13. pii: 10.1007/s00330-020-06923.
PMID: 32405753